EM Biotech
EM Biotech GmbH, founded in 2009 by Dr. Elmar Maier, specializes in supporting life science clients through industry expertise, strategic deal-making, and investment. The company acts as an external business development and licensing resource, facilitating collaborations, negotiations, and transactions in the biotech and pharma sectors. With a strong track record of successful deals, including licensing, M&A, and licensing agreements, EM Biotech aims to create value and growth for its clients in the life sciences industry.
Industries
Nr. of Employees
small (1-50)
Services
Fee-for-service and/or success-fee advisory on licensing, collaboration and partnership opportunities for life-science clients.
Advisory and execution support for M&A, asset sales and corporate transactions, including capital raising for transactions.
Coaching management teams during equity financings, IPO processes and investor negotiations.
Providing interim executives and board-level advisory support to VC-funded life-science companies.
Negotiation of in-licensing and out-licensing agreements, MTAs, sponsored research and technology access arrangements.
Structuring manufacturing, supply and quality agreements, including large-scale vaccine supply and biologics supply arrangements.
Fee-for-service and/or success-fee advisory on licensing, collaboration and partnership opportunities for life-science clients.
Advisory and execution support for M&A, asset sales and corporate transactions, including capital raising for transactions.
Coaching management teams during equity financings, IPO processes and investor negotiations.
Providing interim executives and board-level advisory support to VC-funded life-science companies.
Negotiation of in-licensing and out-licensing agreements, MTAs, sponsored research and technology access arrangements.
Structuring manufacturing, supply and quality agreements, including large-scale vaccine supply and biologics supply arrangements.
Expertise Areas
- Business development & licensing (BD&L)
- Mergers & acquisitions (M&A) advisory
- Deal negotiation and term structuring
- Fundraising and capital markets transactions
Key Technologies
- Vaccines
- Monoclonal antibodies
- Nucleic acid therapeutics and delivery vehicles
- Small molecule drug discovery